Outcome of the Board Meeting held on August 28, 2025

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.4%Reaction day

₹0.93

prior close

₹0.88

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-5.2% vs market

Pharmaceuticals peers, median of 149sector-0.2%-5.2% vs sector

On the reaction day the stock moved 5.2 pts less than Nifty Microcap 250 and 5.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.4-0.2-5.2-0.2-5.2

Next day

-9.7+1.1-10.8+0.6-10.2

-14.0+2.0-15.9+0.4-14.3

-9.7+3.0-12.7+1.5-11.2

-7.5+2.3-9.8+1.3-8.8

-4.3+2.3-6.6+1.2-5.5

+0.0+2.9-2.9+1.1-1.1

15d

-28.0+5.3-33.3+3.0-30.9

-44.1-0.3-43.8-1.9-42.2

-36.6+3.8-40.4-1.2-35.4

-40.9+0.2-41.0-3.8-37.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board of Welcure Drugs & Pharmaceuticals, which met on August 28, 2025, approved plans to raise up to Rs. 80 crores through a Qualified Institutions Placement (QIP) by issuing equity shares. The fundraising will happen in one or more tranches and is subject to shareholder approval via postal ballot. The board also approved the appointment of a merchant banker and constituted a three-member QIP Committee led by Ravi Thakor as Chairman to oversee the issue. Pricing details and the exact number of shares to be issued will be determined later under applicable SEBI rules.

Likely market impact

This is an equity fundraising move that may dilute existing shareholders once shares are allotted. Short-term stock sentiment may depend on the eventual issue price versus the current market price; details on pricing and timing are still awaited.